The text discusses the adjuvant treatment decision for stage II colon cancer based on circulating tumor DNA analysis. It includes a decision tree for treatment options, including surgery, surveillance, and adjuvant chemotherapy. It also mentions the use of oxaliplatin-based adjuvant chemotherapy for stages II and III, with different durations based on risk factors.